DMIIU

Drugs Made In America Acquisition II Corp Unit

74 hedge funds and large institutions have $453M invested in Drugs Made In America Acquisition II Corp Unit in 2025 Q3 according to their latest regulatory filings, with 74 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
RCM
26
Radcliffe Capital Management
Pennsylvania
$5.72M
HCM
27
Heights Capital Management
California
$5.17M
TAL
28
TIG Advisors LLC
New York
$4.97M
HI
29
HBK Investments
Texas
$4.97M
WRBC
30
W.R. Berkley Corp
Connecticut
$4.93M
WA
31
Whitebox Advisors
Minnesota
$4.48M
Verition Fund Management
32
Verition Fund Management
Connecticut
$4.48M
KPF
33
K2 Principal Fund
Ontario, Canada
$4.24M
WC
34
Wealthspring Capital
New York
$4.11M
COPPSERS
35
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$3.98M
RCM
36
Rivernorth Capital Management
Florida
$3.98M
MSU
37
Mizuho Securities USA
New York
$3.79M
Parallax Volatility Advisers
38
Parallax Volatility Advisers
California
$3.7M
CS
39
Clear Street
New York
$3.55M
Toronto Dominion Bank
40
Toronto Dominion Bank
Ontario, Canada
$3.48M
SCM
41
Steadfast Capital Management
New York
$2.98M
SAMU
42
SONA Asset Management (US)
New York
$2.98M
AGM
43
Alpine Global Management
New York
$2.98M
LIP
44
Lighthouse Investment Partners
Florida
$2.98M
PC
45
Periscope Capital
Ontario, Canada
$2.49M
MTCM
46
Mint Tower Capital Management
Netherlands
$2.49M
WCMNY
47
Westchester Capital Management (New York)
New York
$1.99M
MC
48
Meteora Capital
Florida
$1.99M
SCM
49
Saba Capital Management
New York
$1.98M
GCIA
50
Gabelli & Co Investment Advisers
New York
$1.55M